pI: 6.3043 |
Length (AA): 1592 |
MW (Da): 177249 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 12 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
174 | 348 | 1e69 (A) | 1 | 1035 | 29.00 | 0.0000000000031 | 0.76 | 0.17 | 0.58 |
376 | 1179 | 1tr2 (A) | 145 | 970 | 10.00 | 0 | 1 | 0.15 | 0.97 |
684 | 863 | 1gxj (A) | 499 | 657 | 23.00 | 0.0000023 | 1 | 0.27 | -0.31 |
1261 | 1474 | 1w1w (A) | 102 | 1223 | 30.00 | 0 | 0.87 | 0.34 | 0.18 |
1328 | 1457 | 1xew (Y) | 1013 | 1143 | 42.00 | 0 | 1 | 0.77 | -1.74 |
174 | 285 | 4i99 (A) | 2 | 115 | 29.00 | 0.00022 | 0.6 | 0.399152 | -0.13 |
176 | 356 | 3kta (A) | 4 | 168 | 36.00 | 0 | 0.82 | 0.386893 | 0.28 |
179 | 226 | 1w1w (B) | 7 | 54 | 48.00 | 0.044 | 0.73 | 0.527951 | 0.31 |
427 | 580 | 4uos (A) | 9 | 182 | 26.00 | 0.11 | 0.91 | 0.254934 | -0.48 |
548 | 1281 | 1tr2 (A) | 149 | 968 | 23.00 | 0.015 | 1 | 0.450255 | 1.3 |
879 | 1067 | 4uos (A) | 1 | 183 | 8.00 | 0 | 0.03 | 0.213819 | -1.25 |
1297 | 1469 | 1w1w (B) | 180 | 1216 | 39.00 | 0 | 1 | 0.536868 | 0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127440)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G48600 | structural maintenance of chromosomes protein 4 |
Babesia bovis | BBOV_III010300 | SMC family, C-terminal domain containing protein |
Brugia malayi | Bm1_07830 | SMC family, C-terminal domain containing protein |
Candida albicans | CaO19.8579 | potential SMC chromosomal ATPase similar to S. cerevisiae SMC4 (YLR086W) nuclear condensin complex ATPase |
Candida albicans | CaO19.964 | potential SMC chromosomal ATPase similar to S. cerevisiae SMC4 (YLR086W) nuclear condensin complex ATPase |
Caenorhabditis elegans | CELE_F35G12.8 | Protein SMC-4 |
Caenorhabditis elegans | CELE_R13G10.1 | Protein DPY-27 |
Cryptosporidium hominis | Chro.70215 | stable maintenance of chromosomes; Smc4p |
Cryptosporidium parvum | cgd7_1850 | SMC4SMC4, chromosomal ATpase with giant coiled coil regions |
Dictyostelium discoideum | DDB_G0286403 | structural maintenance of chromosome protein |
Drosophila melanogaster | Dmel_CG11397 | gluon |
Echinococcus granulosus | EgrG_000517500 | structural maintenance of chromosomes protein |
Entamoeba histolytica | EHI_199700 | SMC4 protein, putative |
Echinococcus multilocularis | EmuJ_000517500 | structural maintenance of chromosomes protein |
Giardia lamblia | GL50803_17465 | SMC4-like protein |
Homo sapiens | ENSG00000113810 | structural maintenance of chromosomes 4 |
Leishmania braziliensis | LbrM.21.1570 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_211580.1 | RecF/RecN/SMC N terminal domain/SMC proteins Flexible Hinge Domain, putative |
Leishmania infantum | LinJ.21.1580 | hypothetical protein, conserved |
Leishmania major | LmjF.21.1330 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.21.1330partial | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02100 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10473 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10474 | Smc4l1 protein |
Mycobacterium leprae | ML1629c | PROBABLE CHROMOSOME PARTITION PROTEIN SMC |
Mus musculus | ENSMUSG00000034349 | structural maintenance of chromosomes 4 |
Neospora caninum | NCLIV_031540 | chromosome condensation protein, putative |
Oryza sativa | 9267154 | Os05g0497100 |
Onchocerca volvulus | OVOC2348 |
|
Plasmodium berghei | PBANKA_1108700 | structural maintenance of chromosomes protein 4, putative |
Plasmodium falciparum | PF3D7_0509100 | structural maintenance of chromosomes protein 4, putative |
Plasmodium knowlesi | PKNH_1024500 | structural maintenance of chromosomes protein 4, putative |
Plasmodium vivax | PVX_098020 | chromosome condensation protein, putative |
Plasmodium yoelii | PY03258 | chromosome assembly protein xcap-c |
Saccharomyces cerevisiae | YLR086W | condensin subunit SMC4 |
Schistosoma japonicum | Sjp_0302410 | ko:K06675 structural maintenance of chromosome 4, putative |
Schistosoma japonicum | Sjp_0084840 | ko:K06675 structural maintenance of chromosome 4, putative |
Schistosoma mansoni | Smp_173700 | chondroitin sulfate proteoglycan |
Schmidtea mediterranea | mk4.000285.04 | Structural maintenance of chromosomes protein 4 |
Schmidtea mediterranea | mk4.000285.05 | |
Trypanosoma brucei gambiense | Tbg972.10.760 | structural maintenance of chromosome 4, putative |
Trypanosoma brucei | Tb927.10.740 | structural maintenance of chromosome 4, putative |
Trypanosoma brucei | Tb11.v5.0750 | dual specificity protein phosphatase, putative |
Trypanosoma brucei | Tb11.v5.0749 | structural maintenance of chromosome 4, putative |
Trypanosoma congolense | TcIL3000_10_600 | structural maintenance of chromosome 4, putative |
Trypanosoma cruzi | TcCLB.506855.90 | structural maintenance of chromosome protein 4, putative |
Trypanosoma cruzi | TcCLB.508779.90 | structural maintenance of chromosome protein 4, putative |
Toxoplasma gondii | TGME49_231170 | RecF/RecN/SMC N terminal domain-containing protein |
Treponema pallidum | TP0367 | chromosome segregation protein |
Theileria parva | TP02_0117 | hypothetical protein |
Trichomonas vaginalis | TVAG_160280 | condensin subunit Smc4 |
Trichomonas vaginalis | TVAG_434480 | condensin subunit Smc4 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.740 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.740 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.740 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.740 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_R13G10.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_R13G10.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_R13G10.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F35G12.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F35G12.8 | Caenorhabditis elegans | larval arrest | wormbase |
YLR086W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_231170 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2